drugset / Trial / NCT03429556
Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine the safety and efficacy of single intra-operative treatment of Botulinum Neurotoxin Serotype E (EB-001) intramuscular (IM) injections into the Rectus Abdominus (RA) in participants undergoing abdominoplasty.
Timeline
- Start
- 2018-05-08
- Primary completion
- 2018-07-10
- Completion
- 2018-07-10
Outcome
Outcome not reported
Stopped (Business): “Sponsor decision to terminate early”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum Neurotoxin Serotype E | Protein / enzyme biologic | — | Intramuscular |
Indications
No indication recorded.